• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis
CONCLUSION: This study demonstrated that hematologic cancer patients were more susceptible to a severe COVID-19 than patients without blood cancer. Thus, the management of COVID-19 in these patients requires much more attention, and their screening should perform regularly.PMID:35385130 | DOI:10.1002/jcla.24387
Source: Clinical Lymphoma and Myeloma - April 6, 2022 Category: Cancer & Oncology Authors: Adel Naimi Ilya Yashmi Reza Jebeleh Mohammad Imani Mofrad Shakiba Azimian Abhar Yasaman Jannesar Mohsen Heidary Reza Pakzad Source Type: research

Arsenic in medicine: past, present and future
Biometals. 2022 Feb 21:1-19. doi: 10.1007/s10534-022-00371-y. Online ahead of print.ABSTRACTArsenicals are one of the oldest treatments for a variety of human disorders. Although infamous for its toxicity, arsenic is paradoxically a therapeutic agent that has been used since ancient times for the treatment of multiple diseases. The use of most arsenic-based drugs was abandoned with the discovery of antibiotics in the 1940s, but a few remained in use such as those for the treatment of trypanosomiasis. In the 1970s, arsenic trioxide, the active ingredient in a traditional Chinese medicine, was shown to produce dramatic remis...
Source: Biometals - February 22, 2022 Category: Biochemistry Authors: Ngozi P Paul Adriana E Galv án Kunie Yoshinaga-Sakurai Barry P Rosen Masafumi Yoshinaga Source Type: research

In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
ConclusionNatural products or their derivatives may be one of the potential targets to fight against SARS-CoV-2.
Source: Chinese Journal of Integrative Medicine - December 15, 2021 Category: Internal Medicine Source Type: research

Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
This article aims to give an overview on pathogenesis and risk of infectious complications in patients with CLL. In this context, we discuss current data of SARS-CoV-2 infections in patients with CLL and how the pandemic impacts their management.PMID:33631756 | DOI:10.1159/000514071
Source: Acta Haematologica - February 25, 2021 Category: Hematology Authors: Petra Langerbeins Barbara Eichhorst Source Type: research

Pages: 1  2